Natalia Scaramellini
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
EIF2AK1 As a Key Genetic Determinant of Luspatercept Resistance in Transfusion-Dependent Thalassemia.
Journal: American journal of hematology
Published: April 22, 2026
How I manage luspatercept in transfusion-dependent beta-thalassemia.
Journal: HemaSphere
Published: November 09, 2025
Understanding and targeting erythroid cell metabolism.
Journal: Trends in cell biology
Published: July 28, 2025
Iron Chelation Therapy.
Journal: Advances in experimental medicine and biology
Published: July 02, 2025
The Relationship Between Non-Transferrin-Bound Iron (NTBI), Labile Plasma Iron (LPI), and Iron Toxicity.
Journal: International journal of molecular sciences
Published: May 30, 2025
Gene therapy for sickle cell disease and thalassemia.
Journal: Current opinion in hematology
Published: February 27, 2025
A Case of Hodgkin Lymphoma in a Gaucher Disease Patient: Distinguishing Gaucher and Pseudo-Gaucher Cells.
Journal: American journal of hematology
Published: September 28, 2024
Real-world efficacy and safety of luspatercept and predictive factors of response in patients with transfusion-dependent β-thalassemia.
Journal: American journal of hematology
Published: June 29, 2024
Enzyme replacement therapy improves erythropoiesis and iron dysregulation in Gaucher disease.
Journal: Annals of hematology
Published: June 08, 2024
Anemia management and transfusion strategy in internal medicine units: Less is more.
Journal: European journal of internal medicine
Published: February 15, 2023
Iron status in chronic inflammatory disease: therapeutic implications.
Journal: Polish archives of internal medicine
Published: February 13, 2023
Interpreting Iron Homeostasis in Congenital and Acquired Disorders.
Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 24, 2022
Last Updated: 09/26/2026